Lakeshore Biopharma Retains Advisors for Special Committee's Review of Proposal
I'm PortAI, I can summarize articles.
Lakeshore Biopharma Co., Ltd has appointed Kroll, LLC as its financial advisor and retained Gibson, Dunn & Crutcher LLP and Maples and Calder (Hong Kong) LLP as legal counsel for its independent special committee. This is in relation to the review of a revised preliminary non-binding proposal received on August 26, 2025. The company states that no decisions have been made regarding the proposal, and there is no guarantee of any definitive agreement or transaction.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments